Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease. The Indianapolis-based company announced initial results from the research on Thursday and said it plans to submit the drug, ixekizumab, to regulators in the first half of next year.
British drugmaker AstraZeneca says the U.S. Dept. of Justice has closed its investigation into a...
As the oil and gas drilling technique called hydraulic...
The Food and Drug Administration has approved the first screening test for colon cancer that...
Police in New York City are concerned that the increasing popularity of drones in such a tightly packed metropolis could carry major risks, even becoming a potential tool for terrorists to conduct surveillance or carry out attacks. Even though it's illegal to fly the devices just about anywhere in New York City without permission, recent incidents and breathtaking videos of Manhattan suggest that the restrictions are being widely flouted.
The Supreme Court on Thursday tossed out an Australian company's patent for business software in a closely watched case that clarifies standards for awarding patents. The justices ruled unanimously that the government should not have issued a patent to Alice Corp. in the 1990s because the company simply took an abstract idea that has been around for years and programmed it to run through a computer.
Federal health regulators have cleared a genetic test from Roche as the first ever U.S.-approved alternative to the Pap smear, the decades-old mainstay of cervical cancer screening. The U.S. Food and Drug Administration approved Swiss-based Roche's cobas HPV test to detect the human Papillomavirus, or HPV, in women 25 and up. HPV causes nearly all cases of cervical cancer.
Novartis said it's cutting off late-stage research into a potential chronic heart failure treatment because the drug has proven so effective, sending shares to an all-time high when markets opened Monday. Patients taking its twice-daily pill labeled LCZ696 lived longer without being hospitalized for heart failure than those who received a standard of care, Novartis said.
Intelligence officials are planning a sweeping system of electronic monitoring that would tap into government, financial and other databases to scan the behavior of many of the 5 million federal employees with secret clearances. The system is intended to identify rogue agents, corrupt officials and leakers, in part to prevent cases similar to former National Security Agency analyst Edward Snowden.
The Food and Drug Administration on Wednesday approved a cancer drug from Pharmacyclics and Janssen Biotech Inc. for a new use against a rare blood and bone marrow disease. The agency said it approved Imbruvica for patients with chronic lymphocytic leukemia who have already tried at least one other therapy.
A majority of federal health experts said Tuesday that new research is not strong enough to conclude that naproxen, the pain reliever in Aleve and many other medications, is safer on the heart than rival drugs used by millions of Americans to treat arthritis and everyday aches and pains. The Food and Drug Administration advisory panel voted against the conclusion that naproxen has a lower risk of heart attack than ibuprofen.
Federal health experts are taking a second look this week at the heart safety of pain medications used by millions of Americans to treat arthritis and other everyday aches and pains. The Food and Drug Administration holds a two-day meeting beginning Monday to examine the latest research on anti-inflammatory medicines called NSAIDS, which serve as the backbone of U.S. pain treatment.
Some of the world's biggest drugmakers are playing a larger role in anti-doping efforts at this year's Winter Olympics: They're providing information on drugs that once would have been considered proprietary trade secrets. GlaxoSmithKline, Amgen and Roche are among the drugmakers that have begun sharing data about experimental drugs as part of an effort to stay one step ahead of drug cheats.
Just as heart attack symptoms may differ between men and women, so do stroke risks. Now, the American Heart Association has issued its first guidelines for preventing strokes in women. They focus on birth control, pregnancy, depression and other risk factors that women face uniquely or more frequently than men do.
The U.S. Homeland Security Dept. is warning airlines flying to Russia that terrorists may try to smuggle explosives on board hidden in toothpaste tubes. The threat was passed onto airlines that have direct flights to Russia, including some that originate in the U.S., according to a law enforcement official speaking Wednesday on condition of anonymity because he was not authorized to discuss details of the warning.
The Food and Drug Administration said Friday it is reviewing the safety of popular testosterone drugs for men in light of recent studies suggesting they can increase the risk of heart attack, stroke and death. A study suggested testosterone therapy could double the risk of those problems in men older than 65. Another study published in November found that the hormone increased the risk by 30%.
Many patients and physicians assume that the safety and effectiveness of newly approved drugs is well understood by the U.S. Food and Drug Administration (FDA). But a new study by researchers at Yale School of Medicine shows that the clinical trials used by the FDA to approve new drugs between 2005 and 2012 vary widely in their thoroughness.
A panel of federal experts has recommended approval for an experimental blood thinner from Merck despite serious side effects including internal bleeding. The Food and Drug Administration's panel of cardiology experts voted 10-1 Wednesday in favor of approving the pill vorapaxar to help prevent blood clots in patients with a history of heart attacks.
New research finds that the social benefits of autonomous vehicles will outweigh the likely disadvantages. Decreased crashes, increased mobility, and increases in fuel economy will drive the technology forward, says RAND Corp. researchers, despite privacy concerns and need for updates in insurance regulations.
The U.S. Department of Agriculture opened the door Friday to commercial sales of corn and soybean seeds genetically engineered to resist the weed killer 2,4-D, which is best known as an ingredient in the Vietnam War-era herbicide Agent Orange. The U.S. military stopped using Agent Orange in 1971, and it has not been produced since the 1970s.
Biogen Idec said Monday the U.S. Food and Drug Administration (FDA) extended its review of Alprolix, a drug designed to treat hemophilia B. Biogen Idec said the FDA extended its review by three months. The move came after the agency asked Biogen for more information about validation of part of the Alprolix manufacturing process.
Bruker Corp. has announced that it has been granted U.S. FDA clearance under Section 510(k) to market its MALDI Biotyper CA System in the United States for the identification of Gram negative bacterial colonies cultured from human specimens. The clearance marks progress in Bruker’s efforts to develop MALDI-TOF mass spectrometry into the most advanced platform for clinical microbiology identification.
The Food and Drug Administration has ordered Google-backed genetic test maker 23andMe to halt sales of its personalized DNA test kits. In a warning letter posted online Monday, FDA regulators say that the Silicon Valley company has not shown that its tests are safe or effective despite "more than 14 face-to-face and teleconference meetings" and "hundreds of email exchanges."
Within the pharmaceutical industry, the rapid identification, elucidation and characterization of synthetic, process impurities and degradation products is an intense and comprehensive undertaking. In the development of a formulated drug substance, the U.S. Food and Drug Administration (FDA) requires that all impurities introduced in the proposed process above 0.1% must be isolated and fully characterized.
Activists taking part in U.N. climate talks say Japan's decision to drastically scale back its target for reducing greenhouse gas emissions will hurt the battle against global warming. The new target approved by the Japanese Cabinet calls for reducing emissions by 3.8% from their 2005 level by 2020.
The U.S. Food and Drug Administration has approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare and aggressive form of blood cancer. The agency says it approved Imbruvica for patients with mantle cell lymphoma who have already received at least one previous drug therapy.
The widespread use of advanced surveillance technologies by state and local police departments will improve the efficiency of criminal investigations. But a lack of oversight and regulation poses significant privacy concerns, warns Stephen Rushin, a professor of law at the Univ. of Illinois.
Slapping a 20% tax on soda in Britain could cut the number of obese adults by about 180,000, according to a new study. Though the number works out to a modest drop of 1.3% in obesity, scientists say that reduction would still be worthwhile in the U.K., which has a population of about 63 million and is the fattest country in Western Europe. About one in four Britons is obese.
New research from North Carolina State Univ. and the Univ. of Minnesota finds that people in the U.S. want labels on food products that use nanotechnology—whether the nanotechnology is in the food or is used in food packaging. The research also shows that many people are willing to pay more for the labeling.
- Page 1